Objective: The paper analyzes the literature related to medical insurance drug payment standards visually, summarizes the research hotspots and trends in China, and provide reference for improving medical insurance drug payment standards. Methods: Using subjects (drug payment standard or drug payment) and subjects (medical insurance or basic medical insurance) as the search criteria, we retrieved relevant literature from 2000 to 2022 in four Chinese databases, including CNKI, WanFang Database, VIP Network, and Duxiu, and used Citespace software for visualization and analysis. Results: A total of 251 literatures were retrieved, and the research focus on the payment standard of medical insurance drugs is gradually increasing, with a surge in the number of publications in 2015 and a relatively large number of publications from 2018 to 2022. Research institutions are mainly universities, and the cooperation between them needs to be strengthened. The research hotspots are related to the linking role, classification and formulation, dynamic adjustment, improvement of supporting policies and formation mechanism of medical insurance drug payment standards. Conclusion: It is necessary to deal with the balanced relationship between healthcare, medical insurance and medicine, play the role of market to form medical insurance drug payment standards, and implement classified formulation and dynamic adjustment, so that medical insurance drug payment standards can truly reflect quality and value of drugs.
Key words
medical insurance drug payment standard /
Citespace /
visualization analysis
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 向国春. 从德国实践看医保药品支付标准[J].中国社会保障,2018,(01):80-81.
[2] 顾雪非. 医保药品支付标准该如何定?[J].中国卫生,2016,(06):54-56.
[3] 陈斌斌,郝亚伟,董朝晖,等.药品价格指数在医保支付标准中的应用研究[J].中国卫生政策研究,2016,9(06):38-42.
[4] 严妮. 我国医保药品支付标准建设的理论与现实分析[J].中国卫生政策研究,2017,10(11):1-6.
[5] 李伟,周琳,丁锦希,等.药品质量“一致性评价”对我国医保支付标准影响研究[J].价格理论与实践,2016,(08):70-73.
[6] 陈悦,陈超美,刘则渊,等.CiteSpace知识图谱的方法论功能[J].科学学研究,2015,33(02):242-253.
[7] 姚雪,徐川平,李杰,等.基于普赖斯定律和二八定律及在线投稿系统构建某科技期刊核心作者用户库[J].编辑学报,2017,29(01):64-66.
[8] CHENCM.CiteSpaceII:Detecting and visualizing emerging trends and transient patterns in scientific literature[J]. J Am Soc Inf Sci Technol,2006,57(3):359-377.
[9] 唐立健. 医保混合付费方式与支付标准研究综述[J].现代医院管理,2020,18(02):39-42.
[10] 丁锦希,潘越,李伟,等.三医联动政策框架下医保药品支付标准控费机制实证分析[J].中国医疗保险,2017,(09):20-24.
[11] 吴政宇. 利益相关者视角下我国药品价格治理研究[D] ;福州大学,2018.
[12] 唐迪,丁锦希,陈烨,等.医保支付标准与DRG/DIP支付协同推进机制研究[J].中国医疗保险,2021,(03):38-42.
[13] 丁锦希,郝丽,潘越,等.医保支付标准与集中采购联动的螺旋式降价效应及其缓冲阈值设计[J].中国医药工业杂志,2018,49(02):239-247.
[14] 戴国琳,马浩,张可,等.我国仿制药发展现状及对策研究[J].中国医药科学,2022,12(02):185-188.
[15] 傅鸿鹏,陈晓云,张欣,等.药品集中采购的关键问题和对策分析[J].卫生经济研究,2015,(09):7-9.
[16] 罗雪燕,赖寒,王梦媛,等.省级药品集中带量采购模式对比研究[J].卫生经济研究,2022,39(05):7-11.
[17] 董朝晖.对于医保支付标准形成机制的展望[J].中国医疗保险,2015,(07):21-23+29.
[18] 丁锦希,胡雪莹,李伟,等.三医联动政策框架下药品集中采购平台功能完善研究[J].上海医药,2016,37(11):61-65+77.
[19] 丁锦希,潘越,郝丽,等.医保药品支付标准电算化方案设计研究[J].中国医疗保险,2018,(03):17-23.
[20] 朱越,蒋蓉,袁韩时弼,等.基于实证分析的我国药品支付标准制定研究[J].卫生经济研究,2018,(01):50-55.
[21] 丁锦希,薛云霞,李伟,等.药品医保支付标准分类形成机制探究[J].中国医疗保险,2016,(07):9-13.
[22] 袁韩时弼,蒋蓉,任磊,等.医保药品支付标准分类管理研究[J].卫生经济研究,2017,(11):48-51.
[23] 朱玄,董朝晖,徐睿鸿,等.医疗保险不同组织类型下的药品支付标准制定规则与启示[J].中国医疗保险,2018,(03):69-72.
[24] 黄国武,吴迪.医保药品支付标准的形成机制研究[J].中国社会保障,2018,(01):77-79.
[25] 任磊,蒋蓉,袁韩时弼,等.域外典型医保药品支付标准调整的启示——基于斯蒂格利茨政府干预理论[J].卫生经济研究,2018,(03):29-31.
